Poll: Identify the Main Cause for Reverse Switching

Reverse switching occurs when patients transitioned to or initiated on a biosimilar are changed to an originator product, often because of a perceived failure in the biosimilar therapy.

Which do you think is the main reason for reverse switching?

Lack of confidence in biosimilars among health care practitioners
Nocebo/failure to properly educate patients about biosimilars
Differences between biosimilars and originator agents
Lack of clear policy on managing patients with negative outcomes
Related Videos
Michael Kleinrock
Here are the top 5 biosimilar articles for the week of February 13th, 2023.
Ian Henshaw
Ian Henshaw
Ryan Haumschild, PharmD, MS, MBA
Ryan Haumdschild, PharmD
banner for the ophthalmology linkedin live event sponsored by the samsung bioepis in partnership with the center for biosimilars
Ryan Haumschild, PharmD
Nabil Saba
Ryan Haumschild, PharmD
Related Content
© 2023 MJH Life Sciences

All rights reserved.